Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

36.18
BATS BZX Real-Time Price
As of 10:31am ET
 -0.06 / -0.17%
Today’s Change
29.83
Today|||52-Week Range
36.60
+11.39%
Year-to-Date
Dow Jones and S&P 500 Close at New Highs
Oct 19 / GuruFocus News - Paid Partner Content
Nestl speeds up restructuring as sales growth set to weaken
Oct 19 / FT.com - Paid Partner Content
Healthcare ETFs Head to Head: XLV vs. VHT
Oct 19 / Zacks.com - Paid Partner Content
What to Expect from Big Pharmas After J&J's Solid Q3 Results?
Oct 18 / Zacks.com - Paid Partner Content
Why Are These 6 Dow Stocks Fairly Valued?
Oct 19 / GuruFocus News - Paid Partner Content
Reckitt boss hopes to feel no pain after doing the splits
Oct 18 / FT.com - Paid Partner Content
Healthcare ETFs in Focus on Johnson & Johnson Q3 Earnings
Oct 19 / Zacks.com - Paid Partner Content
Biogen (BIIB) Q3 Earnings: Will it Deliver a Beat Again?
Oct 18 / Zacks.com - Paid Partner Content
Conatus Entrusts Keith W. Marshall With Key Management Roles
Oct 19 / Zacks.com - Paid Partner Content
Reckitt Benckiser: fission for compliments
Oct 18 / FT.com - Paid Partner Content

Today’s Trading

Previous close36.24
Today’s open36.30
Day’s range36.14 - 36.31
Volume112,455
Average volume (3 months)17,148,259
Market cap$215.8B
Dividend yield3.54%
Data as of 10:31am ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+6.66%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+8.13%
P/E ratio26.4
Price/Sales3.79
Price/Book3.70

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.50-0.58%
MRKMerck+0.01+0.02%
SNYSanofi-0.47-0.94%
ABBVAbbVie-1.45-1.50%
Data as of 10:31am ET, 10/20/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$0.64
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts